dithiazanine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 930 | 7187-55-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium. A benzothiazole that was formerly used as an antinematodal agent and is currently used as a fluorescent dye.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000871 | Anthelmintics |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000969 | Antinematodal Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D004396 | Coloring Agents |
| MeSH PA | D005456 | Fluorescent Dyes |
| MeSH PA | D007202 | Indicators and Reagents |
| MeSH PA | D049408 | Luminescent Agents |
| CHEBI has role | CHEBI:35443 | anthelmintics |
| CHEBI has role | CHEBI:51217 | fluorochromes |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Dogs | Parasite infestations | Indication |
| Horses | Control of large roundworms, Parascaris equorum | Indication |
| Horses | Control of small strongyles | Indication |
| Horses | Control of large strongyles, Strongylus vulgaris | Indication |
| Horses | Control of pinworms, Oxyuris equi | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Dizan Tablets | Cronus Pharma Specialities India Private Limited | 1 |
| Dizan Powder | Cronus Pharma Specialities India Private Limited | 1 |
| Dizan Suspension With Piperazine | Cronus Pharma Specialities India Private Limited | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.05 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 514-73-8 | SECONDARY_CAS_RN |
| C0012783 | UMLSCUI |
| CHEBI:52806 | CHEBI |
| CHEMBL1185568 | ChEMBL_ID |
| CHEMBL421701 | ChEMBL_ID |
| DB11516 | DRUGBANK_ID |
| D004225 | MESH_DESCRIPTOR_UI |
| 5702698 | PUBCHEM_CID |
| 5L7E7IY5EH | UNII |
| 002981 | NDDF |
| 004970 | NDDF |
| 797929008 | SNOMEDCT_US |
| 89701003 | SNOMEDCT_US |
| 768 | INN_ID |
Pharmaceutical products:
None